Mongolian medicine for treating brucellosis and Mongolian medicine preparation thereof
By using Mongolian medicine made of 21 wei Meng medicinal materials, the existing drugs for treating brucellosis are solved, and high efficacy and safe therapeutic effects are achieved.
Patent Information
- Application Number
- CN202310359532.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-04-04
- Publication Date
- 2025-02-21
- Estimated Expiration
- 2043-04-04
AI Technical Summary
There are problems with insufficient efficacy and increased adverse reactions in existing drugs for treating brucellosis.
Provide a kind of long-haired anemone, kosher, donkey-eared chrysanthemum, leafy thorn bean, purple-flowered aconite, horned fennel, grass black leaves, licorice, coptis chinensis, scutellaria baicalensis, borneol, sophora ginseng, scutellaria ginseng, stone Mongolian medicine and Mongolian medicine preparations made of 21 Mongolian medicinal materials such as calamus, Sichuan black cinnabarum, bamboo yellow, purple ginseng, black ice, earth and wood fragrance, purpura, musk and other 21 kinds of Mongolian medicines.
This Mongolian drug has high compliance and few adverse reactions. It has shown that it has a definite efficacy against brucellosis through a large number of clinical trials, with a total effective efficiency of 92.7%, and no obvious adverse reactions.
Abstract
Description
Technical Field
[0001] The embodiments of the present invention relate to the technical field of public health, and in particular to a Mongolian medicine for treating brucellosis and a Mongolian medicine preparation thereof. Background Art
[0002] Brucellosis (abbreviated as "brucellosis") is a disease caused by Brucella bacteria, which mainly infects cattle, pigs, goats, sheep and dogs. Humans are usually infected through direct contact with infected animals, eating or drinking contaminated animal products, or breathing in pathogens in the air. Most cases are caused by eating unpasteurized goat milk or cheese from infected goats or sheep.
[0003] Brucellosis is one of the most widespread zoonotic diseases spread by animals. In endemic areas, human infection with brucellosis has serious public health consequences. Clinical acute symptoms are mostly long-term fever, sweating, chills, joint swelling and pain, liver and lymph node enlargement; chronic symptoms are mostly headaches, depression, joint pain, etc. After human infection with Brucella, if not treated in time, it is easy to turn into a chronic disease and produce serious complications, which makes treatment difficult and may pose a serious threat to human health.
[0004] At present, the Western medicine treatment for brucellosis is mainly based on anti-infection treatment, and the commonly used drug is doxycycline. During clinical use, it was found that Western medicine treatment has the defects of reduced compliance and increased adverse reactions. Mongolian medicine has the advantages of high compliance and few adverse reactions in the treatment of brucellosis, but there is still the problem of poor treatment effect. Summary of the invention
[0005] To this end, the embodiment of the present invention provides a Mongolian medicine for treating brucellosis and a Mongolian medicine preparation thereof, so as to solve the technical problem that the existing drugs for treating brucellosis have poor effects.
[0006] In order to achieve the above objectives, the embodiments of the present invention provide the following technical solutions:
[0007] According to a first aspect of an embodiment of the present invention, an embodiment of the present invention provides a Mongolian medicine for treating brucellosis, which is made of the following raw materials in parts by weight: 3-7 parts of long-haired anemone, 3-6 parts of terminalia chebula, 3-6 parts of donkey-ear windflower, 2-4 parts of multi-leaf thorn beans, 2-4 parts of purple-flowered Aconitum, 2-4 parts of fennel, 2-4 parts of Aconitum kusnezoffii leaves, 2-4 parts of licorice, 2-4 parts of Coptis chinensis, 2-4 parts of Scutellaria baicalensis, 2-4 parts of borneol, 2-4 parts of Sophora flavescens, 2-4 parts of Cyperus rotundus, 2-4 parts of Acorus calamus, 2-4 parts of processed Chuanwu, 2-4 parts of bamboo yellow, 2-4 parts of purple ginseng, 2-4 parts of black borneol, 2-4 parts of Inula japonica, 2-4 parts of Piper longum, and 0.5-1.5 parts of musk.
[0008] Furthermore, the Mongolian medicine is made of the following raw materials in parts by weight: 5 parts of long-haired anemone, 4.5 parts of terminalia chebula, 4.5 parts of donkey-ear windflower, 3 parts of multi-leaf thorn bean, 3 parts of purple-flowered Aconitum, 3 parts of fennel, 3 parts of Aconitum kusnezoffii leaves, 3 parts of licorice, 3 parts of coptis chinensis, 3 parts of scutellaria baicalensis, 3 parts of borneol, 3 parts of sophora flavescens, 3 parts of cyrtomium, 3 parts of calamus, 3 parts of processed Chuanwu, 3 parts of bamboo pectin, 3 parts of purple ginseng, 3 parts of black borneol, 3 parts of inulin, 3 parts of long pepper, and 1 part of musk.
[0009] According to a second aspect of an embodiment of the present invention, an embodiment of the present invention provides a Mongolian medicine preparation for treating brucellosis, wherein the Mongolian medicine preparation comprises the Mongolian medicine as described above, and a pharmaceutically acceptable carrier or diluent.
[0010] Furthermore, the Mongolian medicine preparation is in the form of pills, granules, powders, tablets or capsules.
[0011] Furthermore, the pharmaceutically acceptable carrier or diluent includes a filler, a binder, a disintegrant, a lubricant or a surfactant.
[0012] According to a third aspect of an embodiment of the present invention, the embodiment of the present invention provides the use of the Mongolian medicine as described above in the preparation of a medicine for treating brucellosis.
[0013] The effects of each raw material of the present invention are as follows:
[0014] Long-haired anemone: The chemical components such as triterpenoid saponins it contains have multiple physiological activities such as anti-tumor, anti-inflammatory, analgesic, and anticonvulsant.
[0015] Terminalia chebula: enters the lung and large intestine meridians. Bitter, sour, astringent, flat. Functions and indications: astringes the intestines and astringes the lungs, reduces fire and relieves sore throat. Used for chronic diarrhea and dysentery, rectal prolapse due to blood in stool, asthma and cough due to lung deficiency, chronic cough, sore throat and hoarseness.
[0016] Donkey Ear Herba Chrysanthemi: bitter; cold in nature, anti-edema medicine. Functions and indications: clearing away heat, detoxifying and dispersing stagnation.
[0017] Oxytropis multifolia: sweet; cold, lung; liver; spleen meridians. Functions and indications: clearing away heat and detoxifying, reducing swelling, removing rheumatism, and stopping bleeding.
[0018] Purple flowered Aconitum: promotes blood circulation and removes blood stasis, dispels wind and dampness, relieves pain and reduces swelling.
[0019] Fennel: bitter, cold, light, rough, thin, abrupt, light and floating. It has the functions of killing stickiness, detoxifying, relieving fever and relieving pain.
[0020] Aconitum leaf: pungent, astringent, neutral; slightly toxic. Functions and indications: clearing away heat, detoxifying, relieving pain. Used for fever, diarrhea, abdominal pain, headache, toothache.
[0021] Licorice: It has the effects of relieving cough and moistening the lungs, nourishing, stopping vomiting, quenching thirst and detoxifying.
[0022] Coptis chinensis: bitter, astringent, cool in nature. Blunt, soft, light, dry. Efficacy: clears heat, dries pus, dries and heals wounds.
[0023] Scutellaria baicalensis: It has the functions of clearing away heat and detoxifying. It is clinically used for toxic and febrile diseases.
[0024] Borneol: It has the effects of invigorating the mind, clearing away heat and relieving pain.
[0025] Sophora flavescens: It is a commonly used medicine in Mongolian medicine, which has the effects of sweating, anti-rheumatic, anti-adhesive disease, anti-inflammatory and analgesic, and treatment of skin diseases.
[0026] Guanzhong: slightly sweet and bitter in taste, cool in nature. Blunt and heavy in effect. Has the effects of clearing heat, detoxifying and healing.
[0027] Acorus calamus: It is applicable to the heart and stomach meridians. It is pungent, bitter and warm. Functions and indications: It can eliminate dampness and stimulate appetite, open the mind and dissipate phlegm, and refresh the mind and improve intelligence.
[0028] Processed Chuanwu: It enters the heart meridian, liver meridian, kidney meridian and spleen meridian. It has the effects of removing cold and dampness, dispersing wind evil, warming the meridians and relieving pain.
[0029] Bamboo yellow: light taste, neutral nature. Enters the lung and liver meridians. Has the effects of resolving phlegm and relieving cough, promoting blood circulation and dispelling wind, and removing dampness.
[0030] Purple ginseng: neutral in nature, bitter and pungent in taste. Functions and indications: clearing away heat and detoxifying, promoting blood circulation, regulating qi and relieving pain.
[0031] Black Borneol: bitter, spicy, warm in nature. Effects: helps digestion, calms constipation, kills stickiness, and relieves abdominal distension.
[0032] Inula: The three flavors are sweet, bitter and spicy, and the nature is neutral. The effects are greasy, sharp, dry and heavy. Efficacy: Clears Bada dry heat, relieves Heyi blood conflict, warms the middle and helps digestion, stimulates appetite, and stops stinging pain.
[0033] Piper longum: It is the immature fruit spike of Piper longum, a perennial herbaceous vine of the Piperaceae family. Efficacy: warms the middle and dispels cold, relieves pain.
[0034] Musk: pungent, bitter, cool, dull, light and greasy. It has the functions of killing sticky insects, detoxifying, opening the orifices, relieving pain, removing yellow water and reducing swelling.
[0035] The embodiments of the present invention have the following advantages:
[0036] The Mongolian medicine provided by the present invention is a traditional prescription with a history of hundreds of years. It is mixed with 21 Mongolian medicinal materials including long-haired anemone, myrobalan, donkey-ear chrysanthemum, multi-leaf thorn bean, purple flower aconite, horn fennel, aconite leaf, liquorice, coptis root, scutellaria baicalensis, borneol, sophora flavescens, cyperus rotundus, calamus, processed Chuanwu, bamboo yellow, purple ginseng, black borneol, scutellaria baicalensis, long piper, and musk, wherein the main prescription of the monarch medicine is long-haired anemone, donkey-ear chrysanthemum, aconite leaf, and Chuanwu (processed) with sterilization. The ministerial medicine has myrobalan, multi-leaf thorn bean, horn fennel, and musk is in harmony with three roots. The adjuvant medicine is guided by the internal organs, helps stomach fire, digestion, and appetizers, and has black borneol, scutellaria baicalensis, long piper. The anti-rheumatic drugs include Radix Sophorae Flavescentis and Borneol; the lung-clearing and cough-relieving drugs include Radix Rhizoma Zinnicarpae, Radix Glycyrrhizae, Radix Aconitum and Radix Ginseng; the heat-clearing, detoxifying and analgesic drugs include Rhizoma Coptidis, Radix Scutellariae and Radix Cynomorium. Through a large number of clinical trials, it can be seen that the Mongolian medicine of the present invention has a definite curative effect on brucellosis.
[0037] The Mongolian medicine preparation for treating brucellosis of the present invention is safe and reliable, has no obvious adverse reaction, has a simple preparation method, is pollution-free to the environment, and has great popularization and application value. DETAILED DESCRIPTION
[0038] The following is a description of the implementation of the present invention by specific embodiments. People familiar with the art can easily understand other advantages and effects of the present invention from the contents disclosed in this specification. Obviously, the described embodiments are part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0039] If no specific techniques or conditions are specified in the examples, the techniques or conditions described in the literature in the field or the product instructions are used. If no manufacturer is specified for the reagents or instruments used, they are all conventional products that can be purchased through regular channels.
[0040] Example 1
[0041] The present embodiment provides a Mongolian medicine for treating brucellosis, which is composed of the following raw materials in parts by weight: 4 parts of long-haired anemone, 3 parts of terminalia chebula, 5 parts of donkey-ear windflower, 3.5 parts of multi-leaf thorn bean, 2 parts of purple-flowered Aconitum, 4 parts of fennel, 3 parts of Aconitum kusnezoffii leaves, 3 parts of liquorice, 2.5 parts of coptis chinensis, 2 parts of scutellaria baicalensis, 2 parts of borneol, 2.5 parts of sophora flavescens, 4 parts of cyrtomium, 2 parts of calamus, 3 parts of processed Chuanwu, 3.5 parts of bamboo pectin, 3.5 parts of purple ginseng, 2.5 parts of black borneol, 4 parts of inulin, 4 parts of long pepper, and 0.8 part of musk.
[0042] Example 2
[0043] The present embodiment provides a Mongolian medicine for treating brucellosis, which is composed of the following raw materials in parts by weight: 5 parts of long-haired anemone, 4.5 parts of terminalia chebula, 4.5 parts of donkey-ear windflower, 3 parts of multi-leaf thorn bean, 3 parts of purple-flowered Aconitum, 3 parts of fennel, 3 parts of Aconitum kusnezoffii leaves, 3 parts of licorice, 3 parts of coptis chinensis, 3 parts of scutellaria baicalensis, 3 parts of borneol, 3 parts of sophora flavescens, 3 parts of cyrtomium, 3 parts of calamus, 3 parts of processed Chuanwu, 3 parts of bamboo pectin, 3 parts of purple ginseng, 3 parts of black borneol, 3 parts of inulin, 3 parts of long pepper, and 1 part of musk.
[0044] Example 3
[0045] The present embodiment provides a Mongolian medicine for treating brucellosis, which is composed of the following raw materials in parts by weight: 7 parts of long-haired anemone, 5 parts of terminalia chebula, 3.5 parts of donkey-ear windflower, 3.5 parts of multi-leaf thorn bean, 3 parts of purple-flowered Aconitum, 2 parts of fennel, 3.5 parts of Aconitum kusnezoffii leaves, 3 parts of licorice, 2.5 parts of coptis chinensis, 3 parts of scutellaria baicalensis, 2 parts of borneol, 2 parts of sophora flavescens, 3 parts of cyrtomium, 4 parts of calamus, 3.5 parts of processed Chuanwu, 2 parts of bamboo pectin, 4 parts of purple ginseng, 3 parts of black borneol, 2 parts of inulin, 3 parts of long pepper, and 1.5 parts of musk.
[0046] Example 4
[0047] The present embodiment provides a Mongolian medicine for treating brucellosis. The Mongolian medicine is composed of the following raw materials in parts by weight: 3 parts of long-haired anemone, 5 parts of terminalia chebula, 5 parts of donkey-ear windflower, 2 parts of multi-leaf thorn bean, 3 parts of purple-flowered Aconitum, 2.5 parts of fennel, 2-4 parts of Aconitum kusnezoffii leaves, 2 parts of liquorice, 3 parts of coptis chinensis, 4 parts of scutellaria baicalensis, 3 parts of borneol, 3.5 parts of sophora flavescens, 3 parts of cyrtomium, 3 parts of calamus, 2 parts of processed Chuanwu, 4 parts of bamboo pectin, 4 parts of purple ginseng, 3 parts of black borneol, 3 parts of inulin, 2 parts of longan, and 1.2 parts of musk.
[0048] Example 5
[0049] The present embodiment provides a Mongolian medicine for treating brucellosis, which is composed of the following raw materials in parts by weight: 5 parts of long-haired anemone, 6 parts of terminalia chebula, 6 parts of donkey-ear windflower, 4 parts of multi-leaf thorn bean, 3 parts of purple-flowered Aconitum, 4 parts of fennel, 3.5 parts of Aconitum kusnezoffii leaves, 2 parts of licorice, 4 parts of coptis chinensis, 4 parts of scutellaria baicalensis, 2 parts of borneol, 3.5 parts of sophora flavescens, 2.5 parts of cyrtomium, 4 parts of calamus, 3 parts of processed Chuanwu, 4 parts of bamboo pectin, 4 parts of purple ginseng, 3 parts of black borneol, 4 parts of inulin, 4 parts of long pepper, and 1.5 parts of musk.
[0050] Example 6
[0051] Take the Mongolian medicine of Examples 1-5, crush the above raw materials, add a pharmaceutically acceptable carrier or diluent, and prepare Mongolian medicine pills according to conventional methods.
[0052] Example 7
[0053] Take the Mongolian medicine of Examples 1-5, crush the above raw materials, add a pharmaceutically acceptable carrier or diluent, and prepare Mongolian medicine granules according to conventional methods.
[0054] Example 8
[0055] Take the Mongolian medicine of Examples 1-5, crush the above raw materials, add a pharmaceutically acceptable carrier or diluent, and prepare Mongolian medicine powder according to a conventional method.
[0056] Example 9
[0057] Take the Mongolian medicine of Examples 1-5, crush the above raw materials, add a pharmaceutically acceptable carrier or diluent, and prepare Mongolian medicine tablets according to conventional methods.
[0058] Example 10
[0059] Take the Mongolian medicine of Examples 1-5, crush the above raw materials, add a pharmaceutically acceptable carrier or diluent, and prepare Mongolian medicine capsules according to conventional methods.
[0060] Clinical trials
[0061] 1. General Information
[0062] A total of 300 patients with brucellosis diagnosed and treated in our hospital from January 2018 to January 2022 were selected. Among them, 201 were male and 99 were female, with an average age of 38.7 years. There were 180 cases with an acute course of less than 6 months and 120 cases with a chronic course of more than 6 months.
[0063] 2. Treatment methods
[0064] Method of taking medicine: The Mongolian medicine of Example 2 is made into granules, taken twice a day, 3g (15 granules) before breakfast and 3g (15 granules) before dinner, and taken with warm water.
[0065] 3. Criteria for determining efficacy
[0066] Refer to the standards set by the National Brucellosis Prevention and Control Conference in 1977:
[0067] Recovery: ① Clinical symptoms and signs disappear, and body temperature returns to normal; ② Work ability and physical strength are restored; ③ Clinical laboratory tests show that the functions of various organs are normal (brucellosis serological reactions may not necessarily turn negative), and those who were originally positive for Brucella culture should have their bacterial culture turned negative twice (with an interval of half a month to one month). And there is no recurrence during the observation period (12 months).
[0068] Markedly effective: Patients whose condition improves after reaching two of the three indicators mentioned above or one or two indicators improve compared with before treatment, but still have mild symptoms, and their working ability is affected to a certain extent, but improved compared with before treatment.
[0069] Ineffective: Symptoms improve in a short period of time after treatment, but relapse after 2-3 weeks of discontinuation of medication.
[0070] 4. Treatment results
[0071] Among the patients who received treatment, 120 were cured, 160 were significantly effective, 22 were ineffective, and the total effective rate was 92.7%. From the treatment results, it can be seen that the Mongolian medicine provided by the present invention is effective in treating brucellosis.
[0072] Typical Cases
[0073] 1. Patient Tong Xiaozhi, male, 29 years old, herdsman, complained of "pain in the dacne for more than 5 months, worsening fever, and fatigue for 2 days." He came to our outpatient department for treatment and completed relevant examinations: blood routine: white blood cell (WBC) 12.6×10 9 / L, mononuclear cell count (MONO#) 1.1×10 9 / L, Brucella determination RBPT (+), STA (1:25): (++++), STA (1:50): (++++), STA (1:100): (++++), STA (1:200): (+++), liver function, kidney function, urine routine, coagulation five items were normal, liver, gallbladder, pancreas and spleen color Doppler ultrasound showed no abnormalities. Diagnosis of "brucellosis" Treatment: Use the Mongolian medicine of Example 2 to make granules, twice a day, 3g (15 grains) before breakfast, 3g (15 grains) before dinner + basic treatment. After 14 days, the patient's large joint pain and fever improved, but fatigue, sweating, loss of appetite, muscle cramps and insomnia did not improve. Complete relevant examinations: Blood routine: White blood cells (WBC) 8.6×10 9 / LMononuclear cell count (MONO#) 0.3×10 9 / L, Brucella assay RBPT (+), STA (1:25): (++++), STA (1:50): (++++), STA (1:100): (-), STA (1:200): (-) test results were significantly improved. Continuing with the same treatment plan, one month later, laboratory test results RBPT (-), STA (1:25): (-), STA (1:50): (-), STA (1:100): (-), STA (1:2000): (-) related symptoms were cured after treatment.
[0074] 2. Patient Guo Weixue, male, 40 years old, veterinarian, complained of "intermittent pain in large joints, fatigue for more than 6 years, and testicular swelling for 3 days." He came to our outpatient department for treatment and completed relevant examinations: blood routine: white blood cell (WBC) 10.6×10 9 / LMononuclear cell count (MONO#) 0.9×10 9 / L, Brucella determination RBPT (+), STA (1:25): (++++), STA (1:50): (++++), STA (1:100): (++++), STA (1:200): (++++) Liver function, kidney function, urine routine, coagulation five items showed no abnormalities. Liver, gallbladder, pancreas and spleen color Doppler ultrasound showed no abnormalities. Diagnosis of "brucellosis" Treatment: Use the Mongolian medicine of Example 2 to make granules, twice a day, 3g (15 grains) before breakfast, 3g (15 grains) before dinner + basic treatment. One month later, the patient's large joint pain and testicular swelling improved, but fatigue, sweating, loss of appetite and insomnia did not improve. Complete relevant examinations, blood routine: white blood cells (WBC) 4.6×10 9 / LMononuclear cell count (MONO#) 0.5×10 9 / L, Brucella assay RBPT (+), STA (1:25): (++++), STA (1:50): (+++), STA (1:100): (-), STA (1:200): (-) The test results were significantly improved. Continuing with the same treatment plan, 2 months later, the laboratory test results RBPT (-), STA (1:25): (-), STA (1:50): (-), STA (1:100): (-), STA (1:200): (-) After treatment, the symptoms of pain in large joints, sweating, muscle spasms, rib pain, abdominal pain, constipation, nausea and vomiting, insomnia, irritability, and testicular swelling in men were cured.
[0075] 3. Patient Saiyinqiqige, female, 52 years old, herder, complained of "intermittent pain in large joints and fatigue for more than 1 year." She came to our outpatient department for treatment and completed relevant examinations: blood routine: white blood cell (WBC) 11.6×10 9 / L, mononuclear cell count (MONO#) 1.7×10 9 / L, Brucella determination RBPT (+), STA (1:25): (++++), STA (1:50): (++++), STA (1:100): (++++), STA (++) Liver function, kidney function, urine routine, coagulation five items were normal, liver, gallbladder, pancreas and spleen color Doppler ultrasound showed no abnormalities. Diagnosis of "brucellosis" Treatment: Use the Mongolian medicine of Example 2 to make granules, twice a day, 3g (15 grains) before breakfast, 3g (15 grains) before dinner + basic treatment. After one month, the patient's large joint pain improved, but fatigue, sweating, loss of appetite, and insomnia did not improve. Complete relevant tests: Blood routine: White blood cells (WBC) 5.6×10 9 / LMononuclear cell count (MONO#) 0.3×10 9 / L, Brucella assay RBPT (+), STA (1:25): (++++), STA (1:50): (+), STA (1:100): (-), STA (1:200): (-) The test results were significantly improved. Continuing with the same treatment plan, one month later, the laboratory test results RBPT (-), STA (1:25): (-), STA (1:50): (-), STA (1:100): (-), STA (1:200): (-) After treatment, the symptoms of large joint pain, fatigue, sweating, loss of appetite, insomnia, etc. were cured.
[0076] 4. Patient Hai Ri, female, 23 years old, student, complained of "intermittent joint pain and irregular menstruation for more than 4 months." She came to our outpatient department for treatment and completed relevant examinations: blood routine: white blood cell (WBC) 11.6×10 9 / LMononuclear cell count (MONO#) 1.9×10 9 / L, Brucella determination RBPT (+), STA (1:25): (++++), STA (1:50): (++++), STA (1:100): (++++), STA (1:200): (++++), liver function, kidney function, urine routine, coagulation five items were normal, gynecological color Doppler ultrasound, liver, gallbladder, pancreas and spleen color Doppler ultrasound were normal. Diagnosis of "brucellosis" treatment: Use the Mongolian medicine of Example 2 to make granules, twice a day, 3g (15 grains) before breakfast, 3g (15 grains) before dinner + basic treatment. After 2 months, the patient's large joint pain improved, but irregular menstruation, fatigue, sweating, loss of appetite and insomnia did not improve. Complete relevant tests: Blood routine: White blood cells (WBC) 4.6×10 9 / LMononuclear cell count (MONO#) 0.×10 9 / L, Brucella test RBPT (+), STA (1:25): (++++), STA (1:50): (+++), STA (1:100): (+), STA (1:200): (-) The test results were significantly improved. Continuing with the same treatment plan, 15 days later, the laboratory test results RBPT (-), STA (1:25): (-), STA (1:50): (-), STA (1:100): (-), STA (1:200): (-) After treatment, the symptoms of pain in large joints, sweating, muscle spasms, abdominal pain, constipation, nausea and vomiting, insomnia, irritability, and irregular menstruation were cured.
[0077] Although the present invention has been described in detail above by general description and specific embodiments, it is obvious to those skilled in the art that some modifications or improvements can be made to the present invention. Therefore, these modifications or improvements made without departing from the spirit of the present invention all belong to the scope of protection claimed by the present invention.
Claims
1. A Mongolian medicine for treating brucellosis, characterized in that: The Mongolian medicine is composed of the following raw materials in parts by weight: 3-7 parts of long-haired anemone, 3-6 parts of terminalia chebula, 3-6 parts of donkey-ear windflower, 2-4 parts of multi-leaf oxtera, 2-4 parts of purple-flowered aconite, 2-4 parts of fennel, 2-4 parts of aconite leaves, 2-4 parts of liquorice, 2-4 parts of coptis root, 2-4 parts of scutellaria baicalensis, 2-4 parts of borneol, 2-4 parts of sophora flavescens, 2-4 parts of cyrtomium, 2-4 parts of calamus, 2-4 parts of processed aconite, 2-4 parts of bamboo pectin, 2-4 parts of purple ginseng, 2-4 parts of black borneol, 2-4 parts of elecampane, 2-4 parts of longan, and 0.5-1.5 parts of musk.
2. The Mongolian medicine for treating brucellosis according to claim 1, characterized in that: The Mongolian medicine is prepared from the following raw materials in parts by weight: 5 parts of long-haired anemone, 4.5 parts of terminalia chebula, 4.5 parts of donkey-ear windflower, 3 parts of multi-leaf thorn bean, 3 parts of purple-flowered Aconitum, 3 parts of horn fennel, 3 parts of Aconitum kusnezoffii leaves, 3 parts of liquorice, 3 parts of coptis chinensis, 3 parts of scutellaria baicalensis, 3 parts of borneol, 3 parts of sophora flavescens, 3 parts of cyrtomium, 3 parts of calamus, 3 parts of processed Chuanwu, 3 parts of bamboo pectin, 3 parts of purple ginseng, 3 parts of black borneol, 3 parts of inulin, 3 parts of long pepper, and 1 part of musk.
3. A Mongolian medicine preparation for treating brucellosis, characterized in that: The Mongolian medicine preparation consists of the Mongolian medicine according to claim 1 or 2, and a pharmaceutically acceptable carrier.
4. The Mongolian medicine preparation according to claim 3, characterized in that: The Mongolian medicine preparation is in the form of pills, granules, powders, tablets or capsules.
5. The Mongolian medicine preparation according to claim 3, characterized in that: The pharmaceutically acceptable carrier includes a diluent, a filler, a binder, a disintegrant, a lubricant or a surfactant.
6. Use of the Mongolian medicine according to claim 1 or 2 in preparing medicine for treating brucellosis.
Citation Information
Patent Citations
Mongolian medicine composition for treating brucellosis, and preparation method thereof
CN112915140A
Mongolian medicine formula for treating Helike tiger disease
CN113769033A